StockData
DNOWNYSEOil & Gas Field Machinery & EquipmentFiscal year ends December 31

DNOW Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$16.21+0.53 (+3.38%)

Close on Oct 19, 2026

Market cap
$2.96B
P/E (TTM)
–
Dividend yield
–

About DNOW

Oil & Gas Field Machinery & Equipment, SIC 3533

DNOW Inc. distributes pipe, valves, fittings, pumps, and related maintenance, repair, and operating supplies, while also fabricating and assembling process and production equipment. The company provides procurement, inventory management, and digital supply chain solutions across three reportable segments: the United States, Canada, and International. Its customer base includes upstream oil and gas exploration and production operators, midstream gathering and transmission providers, gas utilities, downstream refiners, chemical processors, and general industrial manufacturers, as well as enterprises participating in energy transition initiatives.

Headquartered in Houston, Texas, the company employs approximately 5,300 people and maintains a distribution network of about 300 locations globally. This footprint comprises approximately 210 facilities in the United States, around 35 sites in Canada, and roughly 55 locations internationally across the United Kingdom, Europe, Australia, New Zealand, Singapore, and the Middle East, alongside export operations to regions including Africa and Latin America.

Summary of the business section of DNOW's latest annual report, written by StockData.

Company profile

Company

Legal name
DNOW Inc.
Founded
2013
Headquarters
Houston, TX
Address
7402 North Eldridge Parkway 77041
Phone
(281) 823-4700
Employees
5,300, Dec 31, 2025
Industry
Oil & Gas Field Machinery & Equipment
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
Ernst & Young LLP, Houston, Texas

Stock & identifiers

Ticker
DNOW
Exchange
NYSE
Shares outstanding
181M, Jul 29, 2026
Public float
$1.60B, Jun 30, 2025
Filer category
Large accelerated filer
SEC CIK
1599617
CUSIP
67011P100
ISIN
US67011P1003
LEI
549300AVH5SOCFVVDW91
EIN
46-4191184

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
David A. CherechinskyPresident and CEO, Director1,362,077
Raymond W. ChangVP and General Counsel360,388
Mark B. JohnsonSee Remarks340,401
Gillian AndersonVP and CAO69,597
Kelly T. MunsonSee Remarks172,241
Fanny R. SurrattSee Remarks59,572
Terry BonnoDirector124,994
Galen CobbDirector122,594
Paul M. CoppingerDirector78,846
George John DamirisDirector66,341
Richard J. AlarioDirector373,175
Ronald L. JadinDirector66,341
Sonya ReedDirector70,360
Karen David-GreenDirector43,956
Rodney W. EadsDirector115,736

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Mr. Cherechinsky
$7.12M$7.66M$1.43M$185$182
FY2024
Mr Alario
$0$0$1.55M$181$176
FY2024
Mr Cherechinsky
$6.08M$7.02M$1.55M$181$176
FY2024
Mr. Cherechinsky
$6.08M$7.02M$1.55M$181$176
FY2023
Mr Alario
$0$0$1.45M$158$199
FY2023
Mr Cherechinsky
$5.58M$3.13M$1.45M$158$199

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had approximately 5,300 employees, of which approximately 355 were temporary employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Nov 6, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 24, 2025MergerRegistration of securities for a merger or exchange offer (S-4)
May 23, 2025Auditor changeChange in certifying accountant (8-K Item 4.01)
Jan 9, 2024Name changeName changed from NOW Inc. to DNOW Inc.
May 26, 2022DeregistrationTermination of SEC registration (Form 15)
Feb 26, 2014Spin-offRegistration as a new public company (Form 10), e.g. spin-off